×
About 12,206 results

ALLMedicine™ Basal Cell Carcinoma Center

Research & Reviews  5,681 results

Active Surveillance as a Management Option for Low-risk Basal Cell Carcinoma.
https://doi.org/10.1001/jamainternmed.2021.2643
JAMA Internal Medicine; Linos E, Chren MM

Jun 14th, 2021 - Active Surveillance as a Management Option for Low-risk Basal Cell Carcinoma.|2021|Linos E,Chren MM,|

Constitutive Hedgehog/GLI2 signaling drives extracutaneous basaloid squamous cell carci...
https://doi.org/10.1093/carcin/bgab050
Carcinogenesis Grachtchouk M, Liu J et. al.

Jun 12th, 2021 - Uncontrolled activation of the Hedgehog (Hh) signaling pathway, operating through GLI transcription factors, plays a central role in the pathogenesis of cutaneous basal cell carcinoma and contributes to the development of several malignancies aris...

A population-based comparison of organ transplant recipients who develop cutaneous squa...
https://doi.org/10.1016/j.jmr.2021.107003
Journal of the American Academy of Dermatology; Menzies S, O'Leary E et. al.

Jun 11th, 2021 - NMR relaxation dispersion experiments have been widely applied to probe important conformational exchange of macro-molecules in many biological systems. The current improvements in computational techniques as well as the theoretical breakthroughs ...

Polygenic Risk Scores Stratify Keratinocyte Cancer Risk among Solid Organ Transplant Re...
https://doi.org/10.1016/j.jid.2021.03.034
The Journal of Investigative Dermatology; Seviiri M, Law MH et. al.

Jun 5th, 2021 - Solid organ transplant recipients (SOTRs) have elevated risks for basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), especially in high ultraviolet (UV) radiation environments. We assessed whether polygenic risk scores (PRSs) can improv...

Polyunsaturated fatty acid levels and the risk of keratinocyte cancer: A Mendelian Rand...
https://doi.org/10.1158/1055-9965.EPI-20-1765
Cancer Epidemiology, Biomarkers & Prevention : a Publicat... Seviiri M, Law MH et. al.

Jun 5th, 2021 - Keratinocyte cancer (KC) is the commonest cancer, imposing a high economic burden on the healthcare system. Observational studies have shown mixed associations between polyunsaturated fatty acids (PUFAs) and KC; basal cell carcinoma (BCC) and squa...

see more →

Guidelines  31 results

Definitive and Postoperative Radiation Therapy for Basal and Squamous Cell Cancers of t...
https://doi.org/10.1016/j.prro.2019.10.014
Practical Radiation Oncology; Likhacheva A, Awan M et. al.

Dec 13th, 2019 - This guideline reviews the evidence for the use of definitive and postoperative radiation therapy (RT) in patients with basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC). The American Society for Radiation Oncology convened a...

Diagnosis and treatment of basal cell carcinoma: European consensus-based interdiscipli...
https://doi.org/10.1016/j.ejca.2019.06.003
European Journal of Cancer (Oxford, England : 1990); Peris K, Fargnoli MC et. al.

Jul 9th, 2019 - Basal cell carcinoma (BCC) is the most common malignant tumour in white populations. Multidisciplinary experts from the European Dermatology Forum, the European Association of Dermato-Oncology and the European Organization of Research and Treatmen...

High‐frequency ultrasound for diagnosing skin cancer in adults
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013188/full
Dinnes,J.,et al

Dec 7th, 2018 - Early, accurate detection of all skin cancer types is essential to guide appropriate management and to improve morbidity and survival. Melanoma and squamous cell carcinoma (SCC) are high‐risk skin cancers with the potential to metastasise and ulti...

Behavioral Counseling to Prevent Skin Cancer
https://jamanetwork.com/journals/jama/fullarticle/2675556
David C. Grossman

May 19th, 2018 - Skin cancer is the most common type of cancer in the United States. Although invasive melanoma accounts for only 2% of all skin cancer cases, it is responsible for 80% of skin cancer deaths.

Skin Cancer Prevention: Behavioral Counseling
https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/skin-cancer-counseling2
US Preventive Services Task Force

Mar 30th, 2018 - The USPSTF recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin can.

see more →

Drugs  11 results see all →

Clinicaltrials.gov  5,977 results

Active Surveillance as a Management Option for Low-risk Basal Cell Carcinoma.
https://doi.org/10.1001/jamainternmed.2021.2643
JAMA Internal Medicine; Linos E, Chren MM

Jun 14th, 2021 - Active Surveillance as a Management Option for Low-risk Basal Cell Carcinoma.|2021|Linos E,Chren MM,|

Topical Histone Deacetylase Inhibitor Reduced BCC Size in Phase 2 Study
https://www.medscape.com/viewarticle/953042

Jun 13th, 2021 - In the first clinical trial of a topical histone deacetylase (HDAC) inhibitor, remetinostat showed clinical efficacy across several basal cell carcinoma (BCC) tumor types, according to research presented at the annual meeting of the Society for In...

Constitutive Hedgehog/GLI2 signaling drives extracutaneous basaloid squamous cell carci...
https://doi.org/10.1093/carcin/bgab050
Carcinogenesis Grachtchouk M, Liu J et. al.

Jun 12th, 2021 - Uncontrolled activation of the Hedgehog (Hh) signaling pathway, operating through GLI transcription factors, plays a central role in the pathogenesis of cutaneous basal cell carcinoma and contributes to the development of several malignancies aris...

A population-based comparison of organ transplant recipients who develop cutaneous squa...
https://doi.org/10.1016/j.jmr.2021.107003
Journal of the American Academy of Dermatology; Menzies S, O'Leary E et. al.

Jun 11th, 2021 - NMR relaxation dispersion experiments have been widely applied to probe important conformational exchange of macro-molecules in many biological systems. The current improvements in computational techniques as well as the theoretical breakthroughs ...

Polygenic Risk Scores Stratify Keratinocyte Cancer Risk among Solid Organ Transplant Re...
https://doi.org/10.1016/j.jid.2021.03.034
The Journal of Investigative Dermatology; Seviiri M, Law MH et. al.

Jun 5th, 2021 - Solid organ transplant recipients (SOTRs) have elevated risks for basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), especially in high ultraviolet (UV) radiation environments. We assessed whether polygenic risk scores (PRSs) can improv...

see more →

News  483 results

Topical Histone Deacetylase Inhibitor Reduced BCC Size in Phase 2 Study
https://www.medscape.com/viewarticle/953042

Jun 13th, 2021 - In the first clinical trial of a topical histone deacetylase (HDAC) inhibitor, remetinostat showed clinical efficacy across several basal cell carcinoma (BCC) tumor types, according to research presented at the annual meeting of the Society for In...

New Era for Cervical Cancer With Cemiplimab 'Impressive' Results
https://www.medscape.com/viewarticle/951878

May 25th, 2021 - Results from a phase 3 trial showing prolonged survival with the immunotherapy cemiplimab (Libtayo) in the second-line treatment of recurrent or metastatic cervical cancer are being hailed as "practice changing." The drug is not as yet approved fo...

EU Panel Likes Monotherapy Cemiplimab for Two Cancers
https://www.medscape.com/viewarticle/951786

May 24th, 2021 - The immunotherapy cemiplimab (Libtayo) looks set to have two further cancer indications in Europe: nonsmall cell lung cancer (NSCLC) and basal cell carcinoma (BCC). The European Medicines Agency's Committee for Medicinal Products for Human Use (CH...

Hedgehog Inhibitor Alternative Dosing Advantageous for BCC
https://www.medscape.com/viewarticle/948925

Apr 6th, 2021 - Many experts in the treatment of locally advanced or metastatic basal cell carcinoma (BCC) have embraced alternative off-label dosing schedules for the oral hedgehog pathway inhibitors in a successful effort to maintain efficacy while reducing tre...

Cemiplimab Now Approved for Basal Cell Carcinoma
https://www.medscape.com/viewarticle/945602

Feb 9th, 2021 - The Food and Drug Administration has approved cemiplimab-rwlc (Libtayo) as the first immunotherapy to treat patients with locally advanced or metastatic basal cell carcinoma (BCC) previously treated with a hedgehog pathway inhibitor or in whom an ...

see more →

Patient Education  23 results see all →